Kreitzer Anatol sold MPLT
July 17, 2026 · Form 4 insider transaction
Kreitzer Anatol sold 200 shares of MapLight Therapeutics, Inc. at $38.39 per share, a transaction worth $7.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$38.39
Total value
$7.7K
InsiderKreitzer Anatol
RoleOfficer
SecurityVoting Common Stock
Transaction codeS: Open-market sale
Transaction dateJuly 17, 2026
Filing dateJuly 20, 2026
Shares owned after174,906
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025.